[引用][C] Authors' reply to the letter to the editor regarding “Effect of empagliflozin on plasma proprotein convertase subtilisin/kexin type 9 (PCSK9) in patients with type 2 …
In this clinical study, we tested the hypothesis that changes in proprotein convertase
subtilisin/kexin type 9 (PCSK9) levels may contribute to the small increase in fasting LDL …
subtilisin/kexin type 9 (PCSK9) levels may contribute to the small increase in fasting LDL …